News related to Topamax (Topiramate) and/or conditions it is approved for
Topamax May Raise Risk of Birth Defects
Source: MedicineNet Migraine Headache Specialty [2008.07.22]
Title: Topamax May Raise Risk of Birth Defects
Category: Health News
Created: 7/22/2008
Last Editorial Review: 7/22/2008
FDA Approvals: Adderall XR for Adults, Topamax for Migraines, and Others
Source: Medscape Primary Care Headlines [2004.08.19]
The FDA has approved an amphetamine-dextroamphetamine combination (Adderall XR) for use in adults, topiramate (Topamax) for migraine prophylaxis, a new dosing algorithm for radiation therapy (AAA), and two kinds of pentetate (Ca-DTPA and Zn-DTPA) for internal radiation contamination.
Medscape Medical News
Yael Waknine
Exposure To Epilepsy Drugs During Pregnancy Can Increase Birth Defect Risk, Study Finds
Source: Epilepsy News From Medical News Today [2008.07.24]
Pregnant women with epilepsy who took the seizure drug topiramate, which is sold by Johnson and Johnson under the brand name Topamax, increased their risk of having an infant with birth defects, especially when taken in combination with another drug called valproate, according to a study published in the July 22 issue of journal Neurology, the
Epilepsy Drug May Increase Risk Of Birth Defects
Source: Epilepsy News From Medical News Today [2008.07.22]
Taking the epilepsy drug topiramate alone or along with other epilepsy drugs during pregnancy may increase the risk of birth defects, according to a study published in the July 22, 2008, issue of Neurology®, the medical journal of the American Academy of Neurology. Research has shown that many epilepsy drugs increase the risk of birth defects, but little research has been done on topiramate.
|
